United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Aug 17, 2026 · Filed Aug 18, 2026

On Aug 17, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$506.59 for US$4.81M under a trading plan, leaving 324,443 shares. Filed Aug 18, 2026 (Form 4).

Sold
9,500 shares
Price
US$506.59 average (US$501.06 to US$508.17)
Value
US$4.81M
Holding after
324,443 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 17, 2026Common StockOption exercise9,500US$135.42333,943Indirect
Aug 17, 2026Common StockSale213US$501.06333,730Indirect
Aug 17, 2026Common StockSale427US$502.18333,303Indirect
Aug 17, 2026Common StockSale120US$504.21333,183Indirect
Aug 17, 2026Common StockSale1,238US$505.36331,945Indirect
Aug 17, 2026Common StockSale2,521US$506.35329,424Indirect
Aug 17, 2026Common StockSale3,298US$507.43326,126Indirect
Aug 17, 2026Common StockSale1,683US$508.17324,443Indirect

Source

View original at SEC

Related